Expression of nm23 protein in adult soft tissue sarcoma is correlated with histological grade

Anticancer Research

Volumn 23, Issue 4, 2003, Pages 3289-3294

  D'Souza, Rohone J ^a   Sheikh, Zeeshan A ^b   Busund, Lill Tove R ^c   Russell, Pamela J ^a   Crowe, Philip J ^a   Yang, Jia Lin ^a,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Histological grade; Nm23; Nm23 H1; Sarcoma; Tumour markers

Indexed keywords

MONOCLONAL ANTIBODY; NM23 PROTEIN; PARAFFIN; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGING; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE REGRESSION; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; STATISTICAL SIGNIFICANCE; VIDEORECORDING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; REGRESSION ANALYSIS; SARCOMA; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0043031099     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cordon-Cardo C, Brennan MF, Casper ES and Harrison LB: Sarcomas of the soft tissues and bone. In: Cancer: Principles and Practice of Oncology (5th Ed) (DeVita VT, Hellman S and Rosenberg SA, Eds). Philadelphia: Lippincott, 1997. pp2928.
2. Mann GB, Lewis JJ and Brennan MF: Adult soft tissue sarcoma. Aust N Z J Surg 69: 336-343, 1999.
3. Stebbing J, Copson E and O'Reilly S: Herceptin (trastuzamab) in advanced breast cancer. Cancer Treat Rev 26: 287-290, 2000.
4. Steeg PS, Bevilacqua G, Kopper L, Thorgeirrsson UP, Talmadge JE, Liotta LA et al: Evidence for a novel gene associated with low tumour metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
5. Lacombe ML, Milon L, Munier A, Mehus JG and Lambeth DO: The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32: 247-258, 2000.
6. Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH and Rinker-Schaeffer CW: Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol 169: 1122-1133, 2003.
7. Miyazaki H, Fukuda M, Ishijima Y, Takagi Y, Iimura T, Negishi A et al: Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Clin Cancer Res 5: 4301-2327, 1999.
8. Leone A, Seeger R, Hong C, Hu Y, Arboleda M, Brodeur G et al: Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8: 855-865, 1993.
9. Nakagawa Y, Tsumatani K, Kurumatani N, Cho M, Kitahori Y, Konishi N et al: Prognostic value of nm23 protein expression in renal cell carcinomas. Oncology 55: 370-376, 1998.
10. Hamby CV, Abbi R, Prasad N, Stauffer C, Thomson J, Mendola CE et al: Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells. Int J Cancer 88: 547-553, 2000.
11. Berney CR, Yang J-L, Fisher RJ, Russell PJ and Crowe PJ: Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival. World J Surg 22: 484-490, 1998.
12. Einzinger L and Weiss SW: Soft Tissue Tumours (3rd ed). St. Louis: Mosby, 1995.
13. Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V et al: Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 14: 869-877, 1996.
14. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A et al: Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33: 37-42, 1984.
15. Kandel RA, Bell RS, Wunder JS, O'Sullivan B, Catton CN, White LM et al: Comparison between a 2- and 3-grade system in predicting metastatic-free survival in extremity soft-tissue sarcoma. J Surg Oncol 72: 77-82, 1999.
16. Skinner JM, Zhao Y, Coventry B and Bradley J: Video image analysis in pathology. Dis Markers 11: 53-70, 1993.
17. Robinson M, Barr L, Fisher C, Fryar I, Stotter A, Wiltshaw E et al: Treatment of extremity soft tissue sarcomas with surgery and radiotherapy. Radiother Oncol 18: 221-223, 1990.
18. Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F et al: Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 420 adult patients with soft tissue sarcoma. J Clin Oncol 15: 350-362, 1997.
19. Royds JA, Robinson MH, Stephenson TJ, Rees RC and Fisher C: The association between nm23 gene expression and survival in patients with sarcoma. Br J Cancer 75: 1195-1200, 1997.
20. Oda Y, Walter H, Radig K, Rose I, Neumann W and Roessner A: Immunohistochemical analysis of nm23 protein expression in malignant bone turnouts. J Cancer Res Clin Oncol 121: 667-673, 1995.
21. Golouh R, Stanta G, Bracko M and Bonin S: Correlation of MTS1/p16 and nm23 mRNA expression with survival in patients with peripheral synovial sarcoma. J Surg Oncol 76: 83-88, 2001.
22. Bodey B, Groger AM, Siegel SE and Kaiser HE: Nm23/nucleoside diphosphate kinase expression in human malignant melanomas-significance and implications in tumour biology. Anticancer Res 17: 505-511, 1997.
23. Postel EH: Nm23/nucleoside diphosphate kinase as a transciptional activator of c-myc. Curr Top Microbiol Immunol 213: 233-252, 1996.
24. Boxer LM and Dang CV: Translocations involving c-myc and c-myc function. Oncogene 20: 5595-5610, 2001.
25. Barrios C, Castresana JS, Ruiz J and Kreicbergs A: Amplification of the c-myc proto-oncogene in soft tissue sarcomas. Oncology (Huntington) 51: 13-17, 1994.
26. Shen JN, Scotlandi K, Baldini N, Manara MC, Benini S, Cerisano V et al: Prognostic significance of nuclear accumulation of c-myc and mdm-2 proteins in synovial sarcoma of the extremities. Oncology 58: 253-260, 2000.